Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Investing

Pfizer : PFE

All Pfizer Articles

1489 Articles

Douglas A. McIntyre | May 6, 2013 at 6:37 AM EDT

What Is Important in the Financial World

ThinkstockIron Man’s Record Weekend Walt Disney Co.’s (NYSE: DIS) “Iron Man 3” could save the summer box office yield all…

Jon C. Ogg | May 1, 2013 at 10:45 AM EDT

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Biotech stocks come and go as far as the flavor of the day for investors. While many of these companies…

Paul Ausick | Apr 30, 2013 at 10:30 AM EDT

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

ThinkstockDrug giant Pfizer Inc. (NYSE: PFE) this morning reported adjusted earnings and revenues that missed analysts estimates, and the stock…

Jon C. Ogg | Apr 29, 2013 at 1:39 PM EDT

10 Key DJIA Events This Week: Earnings, Meetings, Dividend

This week should mark the climax of first quarter corporate earnings season. It will be a full week for the…

Jon C. Ogg | Apr 29, 2013 at 9:00 AM EDT

Merrill Lynch Lists Six Stocks Poised to Break Out

While the current stock market rally has been impressive since the lows last November, many investors, analysts and equity strategists…

Douglas A. McIntyre | Apr 12, 2013 at 6:20 AM EDT

Media Digest (4/12/2013) Reuters, WSJ, NYT, FT, Bloomberg

courtesy of Facebook Inc.Martha Stewart Omnimedia Inc. (NYSE: MSO) is unable to get a court to dismiss charges by Macy’s…

Jon C. Ogg | Apr 11, 2013 at 8:20 AM EDT

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and…

Jon C. Ogg | Apr 9, 2013 at 11:15 AM EDT

Our Earnings Poll: Which Rivals Will Do Better This Earnings Season? (AAPL, MSFT, JPM, WFC, MRK, PFE, T, VZ)

Jon Ogg24/7 Wall St. wants some insight from readers ahead of earnings season. We have grouped four rival sectors to see…

Douglas A. McIntyre | Mar 19, 2013 at 6:55 AM EDT

Corporate Cash Piles Up

ThinkstockThe debate over how America’s largest companies use cash will pick up again. Moody’s Investor Services released a study that…

Douglas A. McIntyre | Mar 19, 2013 at 6:32 AM EDT

What’s Important in the Financial World (3/19/3013)

ThinkstockCorporate Cash Piles Up The debate over how America’s largest companies use cash will pick up again. Moody’s Investor Services…

Jon C. Ogg | Feb 8, 2013 at 10:10 AM EST

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited…

Jon C. Ogg | Feb 7, 2013 at 8:35 AM EST

Credit Suisse Grows Cautious on Some Big Health Care Stocks (PFE, JNJ, SYK, ABBV)

ThinkstockHave some widely owned health care names hit a wall when it comes to growth and earnings? In a research…

Jon C. Ogg | Feb 7, 2013 at 8:20 AM EST

Top Analyst Upgrades and Downgrades (ABBV, AKAM, BBRY, COCO, DV, GOOG, HLF, JNJ, JCP, MCP, NOK, PFE, SLW, SYK, TE, VCLK, V)

Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AbbVie Inc.…

Jon C. Ogg | Feb 4, 2013 at 5:47 AM EST

Largest Non-Founder CEO Retirement Packages of Modern Business History

ThinkstockCorporate governance issues are sometimes a blessing for shareholders, but they also can crush the rights of shareholders in many cases.…

Paul Ausick | Feb 1, 2013 at 10:23 AM EST

Animal Health Firm IPO Soars (ZTS)

ThinkstockZoetis Inc. (NYSE: ZTS), a spin-off of the animal health business of Pfizer Inc. (NYSE: PFE), held its initial public…

1 … 71 72 73 74 75 … 100

Pfizer : PFE

All Pfizer Articles

What Is Important in the Financial World

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

10 Key DJIA Events This Week: Earnings, Meetings, Dividend

Merrill Lynch Lists Six Stocks Poised to Break Out

Media Digest (4/12/2013) Reuters, WSJ, NYT, FT, Bloomberg

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

Our Earnings Poll: Which Rivals Will Do Better This Earnings Season? (AAPL, MSFT, JPM, WFC, MRK, PFE, T, VZ)

Corporate Cash Piles Up

What’s Important in the Financial World (3/19/3013)

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Credit Suisse Grows Cautious on Some Big Health Care Stocks (PFE, JNJ, SYK, ABBV)

Top Analyst Upgrades and Downgrades (ABBV, AKAM, BBRY, COCO, DV, GOOG, HLF, JNJ, JCP, MCP, NOK, PFE, SLW, SYK, TE, VCLK, V)

Largest Non-Founder CEO Retirement Packages of Modern Business History

Animal Health Firm IPO Soars (ZTS)

Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Live Nasdaq Composite: Markets Hold Breath on Mideast Deal, SpaceX IPO Launch

Bestselling Author: SpaceX Holds Massive Monopoly Power in the Emerging Space Economy

Wall Street Has 18 Buy Ratings on ConocoPhillips and Zero Sells. Our Price Target Says They Are All Wrong

A 65-Year-Old With $1.3M in a 401(k) Avoids the IRMAA Trap With This $50,000 Withdrawal Strategy

A 65-Year-Old With $1.3M in a 401(k) Avoids the IRMAA Trap With This $50,000 Withdrawal Strategy

Big Traveler? What Retirement Really Looks Like at 65 With $1.9 Million

Bestselling Author: SpaceX Holds Massive Monopoly Power in the Emerging Space Economy

Wall Street Has 18 Buy Ratings on ConocoPhillips and Zero Sells. Our Price Target Says They Are All Wrong

Pfizer : PFE

All Pfizer Articles

What Is Important in the Financial World

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

10 Key DJIA Events This Week: Earnings, Meetings, Dividend

Merrill Lynch Lists Six Stocks Poised to Break Out

Media Digest (4/12/2013) Reuters, WSJ, NYT, FT, Bloomberg

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

Our Earnings Poll: Which Rivals Will Do Better This Earnings Season? (AAPL, MSFT, JPM, WFC, MRK, PFE, T, VZ)

Corporate Cash Piles Up

What’s Important in the Financial World (3/19/3013)

﻿﻿JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Credit Suisse Grows Cautious on Some Big Health Care Stocks (PFE, JNJ, SYK, ABBV)

Top Analyst Upgrades and Downgrades (ABBV, AKAM, BBRY, COCO, DV, GOOG, HLF, JNJ, JCP, MCP, NOK, PFE, SLW, SYK, TE, VCLK, V)

Largest Non-Founder CEO Retirement Packages of Modern Business History

Animal Health Firm IPO Soars (ZTS)

Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Live Nasdaq Composite: Markets Hold Breath on Mideast Deal, SpaceX IPO Launch

Bestselling Author: SpaceX Holds Massive Monopoly Power in the Emerging Space Economy

Wall Street Has 18 Buy Ratings on ConocoPhillips and Zero Sells. Our Price Target Says They Are All Wrong

A 65-Year-Old With $1.3M in a 401(k) Avoids the IRMAA Trap With This $50,000 Withdrawal Strategy

Featured Reads

A 65-Year-Old With $1.3M in a 401(k) Avoids the IRMAA Trap With This $50,000 Withdrawal Strategy

Big Traveler? What Retirement Really Looks Like at 65 With $1.9 Million

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)